265120-58-9 Usage
Description
Ropivacaine-iPr-S, also known as (S)-Ropivacaine N-Isopropyl (Ropivacaine EP Impurity E), is a metabolite of (S)-Ropivacaine (R674995). It is a local anesthetic agent that is commonly utilized in medical procedures to provide pain relief. Ropivacaine-iPr-S is characterized by its ability to numb specific areas of the body, allowing for minimal discomfort during surgical or other medical interventions.
Uses
Used in Medical Procedures:
Ropivacaine-iPr-S is used as a local anesthetic for medical procedures, providing pain relief and ensuring patient comfort during interventions. Its effectiveness in numbing targeted areas makes it a valuable asset in various surgical and medical applications.
Used in Epidural Procedures:
In the field of anesthesiology, Ropivacaine-iPr-S is used as a component of epidural anesthesia, particularly for labor analgesia. It helps to alleviate the pain associated with childbirth, allowing expectant mothers to have a more comfortable and manageable labor experience.
Used in Pain Management:
Ropivacaine-iPr-S is also employed in pain management, where it can be used to numb specific areas of the body to reduce discomfort and facilitate recovery from injuries or postoperative pain. Its local anesthetic properties make it a useful tool for healthcare professionals in managing acute and chronic pain conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 265120-58-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,5,1,2 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 265120-58:
(8*2)+(7*6)+(6*5)+(5*1)+(4*2)+(3*0)+(2*5)+(1*8)=119
119 % 10 = 9
So 265120-58-9 is a valid CAS Registry Number.
265120-58-9Relevant articles and documents
Synthesis of dendrimer-type chiral stationary phases based on the selector of (1S,2R)-(+)-2-amino-1,2-diphenylethanol derivate and their enantioseparation evaluation by HPLC
He, Bao-Jiang,Yin, Chuan-Qi,Li, Shi-Rong,Bai, Zheng-Wu
experimental part, p. 69 - 76 (2010/09/09)
In our recent work, a series of dendritic chiral stationary phases (CSPs) were synthesized, in which the chiral selector was L-2-(p-toluenesulfonamido)-3- phenylpropionyl chloride (selector I), and the CSP derived from three-generation dendrimer showed the best separation ability. To further investigate the influence of the structures of dendrimer and chiral selector on enantioseparation ability, in this work, another series CSPs (CSPs 1-4) were prepared by immobilizing (1S,2R)-1,2-diphenyl-2-(3-phenylureido)ethyl 4-isocyanatophenylcarbamate (selector II) on one- to four-generation dendrimers that were prepared in previous work. CSPs 1 and 4 demonstrated the equivalent enantioseparation ability. CSPs 2 and 3 showed the best and poorest enantioseparation ability respectively. Basically, these two series of CSPs exhibited the equivalent enantioseparation ability although the chiral selectors were different. Considering the enantioseparation ability of the CSP derived from aminated silica gel and selector II is much better than that of the one derived from aminated silica gel and selector I, it is believed that the dendrimer conformation essentially impacts enantioseparation.
